Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Surrogacy industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Technology trends
2.1.4 Age group trends
2.1.5 Service provider trends
2.1.6 Regional trends
Chapter 3 Surrogacy Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of infertility cases
3.3.1.2 Rising awareness about the infertility treatment options available in the market
3.3.1.3 Increasing adoption of sedentary lifestyle and unhealthy eating habits leading to hormonal changes
3.3.1.4 Increasing number of fertility clinics
3.3.2 Industry pitfalls & challenges
3.3.2.1 Stringent regulations pertaining commercial surrogacy
3.3.2.2 High cost involved in surrogacy procedure
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By technology
3.4.3 By age group
3.4.4 By service provider
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat of new entrants
3.7.4 Threat of substitutes
3.7.5 Industry rivalry
3.8 PESTEL analysis
3.8.1 Political
3.8.2 Economic
3.8.3 Social
3.8.4 Tecnhological
3.8.5 Environmental
3.8.6 Legal
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Competitive dashboard, 2021
Chapter 5 Surrogacy Market, By Type
5.1 Key segment trends
5.2 Gestational surrogacy
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Traditional surrogacy
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Surrogacy Market, By Technology
6.1 Key segment trends
6.2 Intrauterine insemination (IUI)
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 In-vitro fertilization (IVF)
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.3.2 Classical/standard IVF
6.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3.3 Intracytoplasmic sperm injection (ICSI)
6.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Others
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Surrogacy Market, By Age Group
7.1 Key segment trends
7.2 Below 35 years
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 35-37 years
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 38-39 years
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 40-42 years
7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 43-44 years
7.6.1 Market size, by region, 2018 - 2032 (USD Million)
7.7 Over 44 years
7.7.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Surrogacy Market, By Service Provider
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market size, by region, 2018 - 2032 (USD Million)
8.3 Fertility clinics
8.3.1 Market size, by region, 2018 - 2032 (USD Million)
8.4 Others
8.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 9 Surrogacy Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 Market size, by country, 2018 - 2032 (USD Million)
9.2.2 Market size, by type, 2018 - 2032 (USD Million)
9.2.3 Market size, by technology, 2018 - 2032 (USD Million)
9.2.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.2.4 Market size, by age group, 2018 - 2032 (USD Million)
9.2.5 Market size, by service provider, 2018 - 2032 (USD Million)
9.2.6 U.S.
9.2.6.1 Market size, by type, 2018 - 2032 (USD Million)
9.2.6.2 Market size, by technology, 2018 - 2032 (USD Million)
9.2.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.2.6.3 Market size, by age group, 2018 - 2032 (USD Million)
9.2.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3 Europe
9.3.1 Market size, by country, 2018 - 2032 (USD Million)
9.3.2 Market size, by type, 2018 - 2032 (USD Million)
9.3.3 Market size, by technology, 2018 - 2032 (USD Million)
9.3.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.4 Market size, by age group, 2018 - 2032 (USD Million)
9.3.5 Market size, by service provider, 2018 - 2032 (USD Million)
9.3.6 Czech Republic
9.3.6.1 Market size, by type, 2018 - 2032 (USD Million)
9.3.6.2 Market size, by technology, 2018 - 2032 (USD Million)
9.3.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.6.3 Market size, by age group, 2018 - 2032 (USD Million)
9.3.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3.7 Estonia
9.3.7.1 Market size, by type, 2018 - 2032 (USD Million)
9.3.7.2 Market size, by technology, 2018 - 2032 (USD Million)
9.3.7.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.7.3 Market size, by age group, 2018 - 2032 (USD Million)
9.3.7.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3.8 Georgia
9.3.8.1 Market size, by type, 2018 - 2032 (USD Million)
9.3.8.2 Market size, by technology, 2018 - 2032 (USD Million)
9.3.8.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.8.3 Market size, by age group, 2018 - 2032 (USD Million)
9.3.8.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3.9 Greece
9.3.9.1 Market size, by type, 2018 - 2032 (USD Million)
9.3.9.2 Market size, by technology, 2018 - 2032 (USD Million)
9.3.9.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.9.3 Market size, by age group, 2018 - 2032 (USD Million)
9.3.9.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3.10 Poland
9.3.10.1 Market size, by type, 2018 - 2032 (USD Million)
9.3.10.2 Market size, by technology, 2018 - 2032 (USD Million)
9.3.10.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.10.3 Market size, by age group, 2018 - 2032 (USD Million)
9.3.10.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3.11 Sweden
9.3.11.1 Market size, by type, 2018 - 2032 (USD Million)
9.3.11.2 Market size, by technology, 2018 - 2032 (USD Million)
9.3.11.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.11.3 Market size, by age group, 2018 - 2032 (USD Million)
9.3.11.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.3.12 UK
9.3.12.1 Market size, by type, 2018 - 2032 (USD Million)
9.3.12.2 Market size, by technology, 2018 - 2032 (USD Million)
9.3.12.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.3.12.3 Market size, by age group, 2018 - 2032 (USD Million)
9.3.12.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.4 Asia Pacific
9.4.1 Market size, by country, 2018 - 2032 (USD Million)
9.4.2 Market size, by type, 2018 - 2032 (USD Million)
9.4.3 Market size, by technology, 2018 - 2032 (USD Million)
9.4.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.4.4 Market size, by age group, 2018 - 2032 (USD Million)
9.4.5 Market size, by service provider, 2018 - 2032 (USD Million)
9.4.6 India
9.4.6.1 Market size, by type, 2018 - 2032 (USD Million)
9.4.6.2 Market size, by technology, 2018 - 2032 (USD Million)
9.4.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.4.6.3 Market size, by age group, 2018 - 2032 (USD Million)
9.4.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.4.7 Thailand
9.4.7.1 Market size, by type, 2018 - 2032 (USD Million)
9.4.7.2 Market size, by technology, 2018 - 2032 (USD Million)
9.4.7.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.4.7.3 Market size, by age group, 2018 - 2032 (USD Million)
9.4.7.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.4.8 South Korea
9.4.8.1 Market size, by type, 2018 - 2032 (USD Million)
9.4.8.2 Market size, by technology, 2018 - 2032 (USD Million)
9.4.8.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.4.8.3 Market size, by age group, 2018 - 2032 (USD Million)
9.4.8.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.5 Africa
9.5.1 Market size, by country, 2018 - 2032 (USD Million)
9.5.2 Market size, by type, 2018 - 2032 (USD Million)
9.5.3 Market size, by technology, 2018 - 2032 (USD Million)
9.5.3.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.5.4 Market size, by age group, 2018 - 2032 (USD Million)
9.5.5 Market size, by service provider, 2018 - 2032 (USD Million)
9.5.6 Kenya
9.5.6.1 Market size, by type, 2018 - 2032 (USD Million)
9.5.6.2 Market size, by technology, 2018 - 2032 (USD Million)
9.5.6.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.5.6.3 Market size, by age group, 2018 - 2032 (USD Million)
9.5.6.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.5.7 Nigeria
9.5.7.1 Market size, by type, 2018 - 2032 (USD Million)
9.5.7.2 Market size, by technology, 2018 - 2032 (USD Million)
9.5.7.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.5.7.3 Market size, by age group, 2018 - 2032 (USD Million)
9.5.7.4 Market size, by service provider, 2018 - 2032 (USD Million)
9.5.8 South Africa
9.5.8.1 Market size, by type, 2018 - 2032 (USD Million)
9.5.8.2 Market size, by technology, 2018 - 2032 (USD Million)
9.5.8.2.1 Market size, by in-vitro fertilization (IVF), 2018 - 2032 (USD Million)
9.5.8.3 Market size, by age group, 2018 - 2032 (USD Million)
9.5.8.4 Market size, by service provider, 2018 - 2032 (USD Million)
Chapter 10 Company Profiles
10.1 IVIRMA
10.1.1 Business overview
10.1.2 Financial data
10.1.3 Service landscape
10.1.4 Strategic outlook
10.1.5 SWOT analysis
10.2 Boston IVF
10.2.1 Business overview
10.2.2 Financial data
10.2.3 Service landscape
10.2.4 Strategic outlook
10.2.5 SWOT analysis
10.3 Ovation Fertility
10.3.1 Business overview
10.3.2 Financial data
10.3.3 Service landscape
10.3.4 Strategic outlook
10.3.5 SWOT analysis
10.4 Extraordinary Conceptions
10.4.1 Business overview
10.4.2 Financial data
10.4.3 Service landscape
10.4.4 Strategic outlook
10.4.5 SWOT analysis
10.5 Circle Surrogacy
10.5.1 Business overview
10.5.2 Financial data
10.5.3 Service landscape
10.5.4 Strategic outlook
10.5.5 SWOT analysis
10.6 Growing Generations
10.6.1 Business overview
10.6.2 Financial data
10.6.3 Service landscape
10.6.4 Strategic outlook
10.6.5 SWOT analysis
10.7 New Hope Fertility Clinic
10.7.1 Business overview
10.7.2 Financial data
10.7.3 Service landscape
10.7.4 Strategic outlook
10.7.5 SWOT analysis
10.8 Bourn Hall International (TVM Capital Healthcare)
10.8.1 Business overview
10.8.2 Financial data
10.8.3 Service landscape
10.8.4 Strategic outlook
10.8.5 SWOT analysis
10.9 NOVA IVF
10.9.1 Business overview
10.9.2 Financial data
10.9.3 Service landscape
10.9.4 Strategic outlook
10.9.5 SWOT analysis
10.10 MLSPL (Morpheus IVF Clinic)
10.10.1 Business overview
10.10.2 Financial data
10.10.3 Service landscape
10.10.4 Strategic outlook
10.10.5 SWOT analysis
10.11 Max Healthcare
10.11.1 Business overview
10.11.2 Financial data
10.11.3 Service landscape
10.11.4 Strategic outlook
10.11.5 SWOT analysis
10.12 Scanfert Clinic
10.12.1 Business overview
10.12.2 Financial data
10.12.3 Service landscape
10.12.4 Strategic outlook
10.12.5 SWOT analysis
10.13 Bangkok IVF Center
10.13.1 Business overview
10.13.2 Financial data
10.13.3 Service landscape
10.13.4 Strategic outlook
10.13.5 SWOT analysis
10.14 Houston Fertility Center
10.14.1 Business overview
10.14.2 Financial data
10.14.3 Service landscape
10.14.4 Strategic outlook
10.14.5 SWOT analysis
